Studies showed that the CD44 variant (CD44v), a cell adhesion molecule widely expressed in various CSCs controls the intracellular levels of reduced GSH by directly interacting with the h SLC7A11, thereby promoting tumor growth [40]. Here, SLC7A11 is linked to neoplasm.